Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.059 | 0.07 |
mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.07 |
mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.33 | 0.07 |
mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.07 |
mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.07 |
mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |